查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1412529

疱疹标记检测市场：按适应症、检测类型和应用分类 - 2024-2030 年全球预测

Herpes Marker Testing Market by Indication (HSV-1, HSV-2), Test Type (Antibody or Antigen-based Kits, Nucleic Acid Amplification based Kits, Viral Culture Test), Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年疱疹标记检测市场规模为4.6822亿美元，预计2024年将达到4.9786亿美元，2030年将达到7.2583亿美元，复合年增长率为6.46%。

疱疹标记物测试的全球市场

主要市场统计
基准年[2023] 46822万美元
预测年份 [2024] 4.9786 亿美元
预测年份 [2030] 72583万美元
复合年增长率（%） 6.46%
疱疹标记测试市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估疱疹标记检测市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对疱疹标记物测试市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-疱疹标记物检测市场的市场规模和预测是多少？

2-在疱疹标记测试市场的预测期内，需要考虑投资哪些产品、细分市场、应用和领域？

3-疱疹标誌物检测市场的技术趋势和法律规范是什么？

4-疱疹标记物测试市场主要供应商的市场占有率是多少？

5-进入疱疹标誌物检测市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人群中疱疹感染疾病的盛行率
      • 提高对口腔和生殖器感染疾病的早期诊断和治疗的认识
      • 增加医疗支出并改善医疗基础设施
    • 抑制因素
      • 由于缺乏技术人员，可用实验室数量有限
    • 机会
      • 介绍新开发的疱疹检测套组
      • 治疗疱疹感染疾病的新疫苗的研究活动扩大
    • 任务
      • 严格而漫长的核准流程
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章 疱疹标记测试市场（按适应症）

  • HSV-1
  • HSV-2

第七章按测试类型分類的疱疹标记测试市场

  • 基于抗体或抗原的套件
  • 基于核酸扩增的套件
  • 病毒培养测试

第八章疱疹标记测试市场：按应用分类

  • 临床
  • 调查

第九章 北美和南美疱疹标记检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区疱疹标记检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲疱疹标记检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：按主要企业划分
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • Abcam PLC
    • AdvaCare Pharma
    • Bio-Diagnostics Ltd.
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Biopanda Reagents Ltd.
    • CTK Biotech, Inc.
    • DiaSorin SpA
    • F. Hoffmann-La Roche Ltd.
    • Genome Diagnostics Pvt. Ltd.
    • Hologic, Inc.
    • InTec PRODUCTS, INC.
    • Merck KGaA
    • Meridian Bioscience, Inc. by SD Biosensor, Inc.
    • Norgen Biotek Corporation
    • QED Bioscience, Inc.
    • Qiagen NV
    • Quidel Corporation
    • Rapid STD Testing by RSC Health, PA
    • Teco Diagnostics
    • Thermo Fisher Scientific, Inc.
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-DD0700E81D13

[194 Pages Report] The Herpes Marker Testing Market size was estimated at USD 468.22 million in 2023 and expected to reach USD 497.86 million in 2024, at a CAGR 6.46% to reach USD 725.83 million by 2030.

Global Herpes Marker Testing Market

KEY MARKET STATISTICS
Base Year [2023] USD 468.22 million
Estimated Year [2024] USD 497.86 million
Forecast Year [2030] USD 725.83 million
CAGR (%) 6.46%
Herpes Marker Testing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Herpes Marker Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Herpes Marker Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Herpes Marker Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, AdvaCare Pharma, Bio-Diagnostics Ltd., Bio-Rad Laboratories, Inc., bioMerieux SA, Biopanda Reagents Ltd., CTK Biotech, Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Genome Diagnostics Pvt. Ltd., Hologic, Inc., InTec PRODUCTS, INC., Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor, Inc., Norgen Biotek Corporation, QED Bioscience, Inc., Qiagen N.V., Quidel Corporation, Rapid STD Testing by RSC Health, PA, Teco Diagnostics, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Herpes Marker Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • HSV-1
    • HSV-2
  • Test Type
    • Antibody or Antigen-based Kits
    • Nucleic Acid Amplification based Kits
    • Viral Culture Test
  • Application
    • Clinical
    • Research
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Herpes Marker Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Herpes Marker Testing Market?

3. What are the technology trends and regulatory frameworks in the Herpes Marker Testing Market?

4. What is the market share of the leading vendors in the Herpes Marker Testing Market?

5. Which modes and strategic moves are suitable for entering the Herpes Marker Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Herpes Marker Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of herpes infections among population
      • 5.1.1.2. Growing awareness of early diagnosis and treatments of oral and genital infection
      • 5.1.1.3. Rising healthcare spendings and improved healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of laboratories along with lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of newly developed herpes testing kits
      • 5.1.3.2. Growing research activities for novel vaccines to treat herpes infections
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent and time consuming approval processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Herpes Marker Testing Market, by Indication

  • 6.1. Introduction
  • 6.2. HSV-1
  • 6.3. HSV-2

7. Herpes Marker Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Antibody or Antigen-based Kits
  • 7.3. Nucleic Acid Amplification based Kits
  • 7.4. Viral Culture Test

8. Herpes Marker Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical
  • 8.3. Research

9. Americas Herpes Marker Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Herpes Marker Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Herpes Marker Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Abcam PLC
    • 13.1.3. AdvaCare Pharma
    • 13.1.4. Bio-Diagnostics Ltd.
    • 13.1.5. Bio-Rad Laboratories, Inc.
    • 13.1.6. bioMerieux SA
    • 13.1.7. Biopanda Reagents Ltd.
    • 13.1.8. CTK Biotech, Inc.
    • 13.1.9. DiaSorin S.p.A.
    • 13.1.10. F. Hoffmann-La Roche Ltd.
    • 13.1.11. Genome Diagnostics Pvt. Ltd.
    • 13.1.12. Hologic, Inc.
    • 13.1.13. InTec PRODUCTS, INC.
    • 13.1.14. Merck KGaA
    • 13.1.15. Meridian Bioscience, Inc. by SD Biosensor, Inc.
    • 13.1.16. Norgen Biotek Corporation
    • 13.1.17. QED Bioscience, Inc.
    • 13.1.18. Qiagen N.V.
    • 13.1.19. Quidel Corporation
    • 13.1.20. Rapid STD Testing by RSC Health, PA
    • 13.1.21. Teco Diagnostics
    • 13.1.22. Thermo Fisher Scientific, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. HERPES MARKER TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. HERPES MARKER TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HERPES MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. HERPES MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HERPES MARKER TESTING MARKET DYNAMICS
  • FIGURE 7. HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 10. HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. HERPES MARKER TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 6. HERPES MARKER TESTING MARKET SIZE, BY HSV-1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HERPES MARKER TESTING MARKET SIZE, BY HSV-2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. HERPES MARKER TESTING MARKET SIZE, BY ANTIBODY OR ANTIGEN-BASED KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. HERPES MARKER TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION BASED KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. HERPES MARKER TESTING MARKET SIZE, BY VIRAL CULTURE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. HERPES MARKER TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. HERPES MARKER TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 143. HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. HERPES MARKER TESTING MARKET LICENSE & PRICING